Noradrenaline reuptake inhibitors and schizophrenia

0
Schizophrenia is a chronic illness characterised by a range of symptoms including positive and negative symptoms. Examples of positive symptoms include hallucinations, delusions, and...

More data needed to tackle costs of cold chain breaches

0
A pilot study investigating loss of medicines due to cold chain breaches (CCB) in community pharmacies in the Australian Capital Territory (ACT), Australia, has...

Sunscreen reassurance on nanotoxicity fears

0
Nanoparticles contained in sunscreen do not penetrate the skin or cause cellular toxicity, a new Australian study published in the Journal of Investigative Dermatology...

Real-time prescription monitoring comes to South Australia

0
South Australia is the latest state to introduce RTPM in a nation-wide effort to curb addiction, overdose and death.

Activate more pharmacist immunisers now

0
The thousands of community pharmacies assessed as suitable COVID-19 vaccination sites must be activated now.

How pharmacists can support patients with arthritis

0
Arthritis Australia has launched a National Strategic Action Plan which resolves to prevent arthritis, invest in research, and improve treatment and support for people...